SecBot SecBot
144 ·Filed Apr 28, 2026

DYN

Dyne Therapeutics, Inc.
BEARISH
Impact 5/10
Horizondays Processed6mo ago SEC0001628280-26-027983
Form 144, notice of proposed sale of securities
Actionable Insight ▼ Bearish

The Form 144 filing by a founding venture investor, combined with heavy insider selling over the past month, suggests potential continued distribution. Monitor for subsequent Form 4 filings to confirm actual sales, and watch for any operational updates or clinical data that could offset the negative signal.

DirectionBearish
Confidencehigh
Horizondays

How the stock moved after the report

⚠ Clustered BEARISH VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$17.41
T+0 close · Apr 28, 2026 · via day close
Latest settled
+40.38%
T+60 · $24.44
Vs SPY
+36.27%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Apr 29 $17.41entry
  2. T+1 · 7mo ago +0.80%α −0.22% · $17.55
  3. T+5 · 7mo ago +8.21%α +5.10% · $18.84
  4. T+20 · 6mo ago +6.61%α +0.56% · $18.56
  5. T+60 · 4mo ago +40.38%α +36.27% · $24.44

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Atlas Venture Opportunity Fund I, L.P., a major venture capital backer of Dyne Therapeutics, filed a Form 144 notice of intent to sell 47,103 shares of common stock, with an approximate market value of $849,738 based on the filing date. This represents a relatively small portion of the fund's holdings and the company's $3.0B market cap, but the sale comes amid heavy recent insider selling ($13.2M over 30 days) and may signal a gradual exit by a founding investor.

Key Facts

  • Atlas Venture Opportunity Fund I, L.P. filed Form 144 to sell 47,103 shares of DYN common stock.
  • Estimated aggregate market value of the proposed sale is $849,738.12.
  • The shares were acquired in a private placement on August 7, 2020.
  • Over the past 30 days, there have been 10 insider sells totaling $13.2M.
  • The company has a market cap of approximately $3.0B.
  • The filing date is April 28, 2026.

Financial Impact

Proposed sale of ~$850K in stock, representing a small fraction of the company's $3.0B market cap.

dilution

Risk Factors

  • Continued insider selling could pressure the stock price.
  • The sale by a prominent early investor may signal reduced confidence in near-term prospects.
  • Heavy insider selling cluster may precede negative news or a downturn.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
85% bullish (20 analysts)

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001628280-26-027983
Document: 0001628280-26-027983-index.html0001628280-26-027983
Document: 0001628280-26-027983.txt0001628280-26-027983

Track record

54 reports on DYN

Performance horizon

12 of 15 bullish or bearish reports moved the stock their way by T+20. Best: +46.36% at T+60 after the May 20, 2026 report. 15 of 15 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G Neutral 3/10 Entry $16.77 Now $16.70 −0.39% settles Dec 15
  2. Nov 13, 20263d ago 144 Neutral 2/10 Entry $17.16 Now $16.70 −2.68% settles Dec 15
  3. Nov 13, 20263d ago 144 Neutral 2/10 Entry $17.16 Now $16.70 −2.68% settles Dec 15
  4. Nov 5, 202611d ago 8-K Neutral 5/10 No price data
  5. Nov 5, 202611d ago Press Release Neutral 5/10 Entry $17.36 Now $16.70 −3.80% settles Dec 4
  6. Oct 29, 202618d ago Institutional Cluster Neutral 2/10 Entry $17.04 Now $16.70 −2.00% settles Nov 27
  7. Oct 22, 202625d ago Press Release Neutral 2/10 Entry $15.62 Now $16.70 +6.91% settles Nov 20
  8. Oct 12, 20265w ago Institutional Cluster Mixed 4/10 Entry $15.96 to $18.62 Now $16.70 +4.64% ▲ +16.67% +19.93% vs SPY
  9. Sep 29, 20266w ago Press Release Bullish 7/10 Entry $16.11 to $16.94 Now $16.70 +3.66% ▲ +5.15% +4.23% vs SPY
  10. Sep 8, 20269w ago Insider Cluster Neutral 3/10 Entry $19.19 to $15.97 Now $16.70 −12.98% ▼ −16.78% −18.72% vs SPY
Showing 10 of 54

US Market Status

Market Closed · Opens in 9h 27m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Apr 28, 2026